anti-pCdk2 polyclonal (Santa Cruz) au 1/1000, anti-PARP clivée polyclonal, 1000. ,
× 5 min) avant d'être marquée pendant 1 h avec un anticorps secondaire couplé à la peroxydase de Raifort (HRP) : anti-IgG de lapin préparé chez la chèvre ,
Les cellules sont ensuite fixées et perméabilisées dans l'éthanol à 80 % puis sont stockées à -20°C jusqu'au moment de l'analyse. Le marquage à l'iodure de propidium ,
Molecular targets of dietary agents for prevention and therapy of cancer, Biochemical Pharmacology, vol.71, issue.10 ,
DOI : 10.1016/j.bcp.2006.02.009
Resveratrol causes WAF-1/p21-mediated G(1)- phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells ,
The Catalytic Acid in the Dephosphorylation of the Cdk2-pTpY/CycA Protein Complex by Cdc25B Phosphatase, The Journal of Physical Chemistry B, vol.112, issue.47, pp.15244-15247, 2008. ,
DOI : 10.1021/jp8070019
Flexibility and inhibitor binding in cdc25 phosphatases, Proteins: Structure, Function, and Bioinformatics, vol.465, issue.14, 2010. ,
DOI : 10.1002/cmdc.200500092
Moderate variations in CDC25B protein levels modulate the response to DNA damaging agents, Cell Cycle, vol.7, issue.14, pp.2234-2240, 2008. ,
DOI : 10.4161/cc.7.14.6305
URL : https://hal.archives-ouvertes.fr/hal-00317265
Cell Cycle Control by the CDC25 Phosphatases, Anti-Cancer Agents in Medicinal Chemistry, vol.8, issue.8 ,
DOI : 10.2174/187152008786847756
Reversal of P-glycoprotein-mediated multidrug resistance by diallyl sulfide in K562 leukemic cells and in mouse liver, Carcinogenesis, vol.25, issue.6, pp.941-949, 2004. ,
DOI : 10.1093/carcin/bgh060
Resveratrol: A Review of Pre-clinical Studies for Human Cancer Prevention, Toxicol. Appl. Pharmacol, pp.224-274, 2007. ,
Cdc25C phosphorylation on serine 191 by Plk3 promotes its nuclear translocation, Oncogene, vol.23, issue.15, pp.2658-2663, 2004. ,
DOI : 10.1074/jbc.M008151200
Phosphorylation of Human CDC25B Phosphatase by CDK1-Cyclin A Triggers Its Proteasome-dependent Degradation, Journal of Biological Chemistry, vol.10, issue.52, pp.272-32731, 1997. ,
DOI : 10.1101/gad.7.5.812
Induction of Cdc25B Regulates Cell Cycle Resumption after Genotoxic Stress, Cancer Research, vol.67, issue.7 ,
DOI : 10.1158/0008-5472.CAN-06-3685
Design and Synthesis of Macrocyclic Inhibitors of Phosphatase Cdc25B., ChemInform, vol.14, issue.34 ,
DOI : 10.1002/chin.200434105
Synthesis of Diarylamines in the Thiophene Series by Buchwald???Hartwig Coupling., ChemInform, vol.37, issue.4, pp.2373-2378, 2005. ,
DOI : 10.1002/chin.200604102
Reactivity of substituted bromothiophenecarboxylates in palladium-catalyzed N-arylation of hetarylamines, Synthesis, vol.16, pp.2794-2798, 2006. ,
Palladium-catalyzed Buchwald-Hartwig coupling of deactivated aminothiophenes with substituted halopyridines, Eur. J. Org. Chem, vol.10, pp.1678-1682, 2007. ,
Estimation nationale de l'incidence et de la mortalité par cancer en France entre, 1980. ,
Synthesis and biological evaluation of chalcones and their derived pyrazoles as potential cytotoxic agents, Bioorganic & Medicinal Chemistry Letters, vol.15, issue.12 ,
DOI : 10.1016/j.bmcl.2005.03.121
Dysidiolide and related ??-hydroxy butenolide compounds as inhibitors of the protein tyrosine phosphatase, CDC25, Bioorganic & Medicinal Chemistry Letters, vol.9, issue.17, pp.2537-2538, 1999. ,
DOI : 10.1016/S0960-894X(99)00431-X
A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase, Current Biology, vol.9, issue.1, pp.1-10, 1999. ,
DOI : 10.1016/S0960-9822(99)80041-4
/S Transition and Leads to Premature Activation of Cyclin E- and Cyclin A-Dependent Kinases, Molecular and Cellular Biology, vol.19, issue.9, pp.6183-6194, 1999. ,
DOI : 10.1128/MCB.19.9.6183
Characterization of centrosomal localization and dynamics of Cdc25C phosphatase in mitosis, Cell Cycle, vol.7, issue.13, 1991. ,
DOI : 10.4161/cc.7.13.6095
URL : https://hal.archives-ouvertes.fr/hal-00350866
The when and wheres of CDC25 phosphatases, Current Opinion in Cell Biology, vol.18, issue.2, pp.185-191, 2006. ,
DOI : 10.1016/j.ceb.2006.02.003
URL : https://hal.archives-ouvertes.fr/hal-00317392
CDC25B Involvement in the Centrosome Duplication Cycle and in Microtubule Nucleation, Cancer Research, vol.67, issue.24, pp.11557-11564, 2007. ,
DOI : 10.1158/0008-5472.CAN-07-2415
URL : https://hal.archives-ouvertes.fr/hal-00317336
CDC25 phosphatases in cancer cells: key players? Good targets?, Nature Reviews Cancer, vol.20, issue.7, pp.495-507, 2007. ,
DOI : 10.1158/0008-5472.CAN-05-1054
URL : https://hal.archives-ouvertes.fr/hal-00317350
Novel naphthoquinone and quinolinedione inhibitors of CDC25 phosphatase activity with antiproliferative properties, Bioorganic & Medicinal Chemistry, vol.16, issue.19, pp.16-9040, 2008. ,
DOI : 10.1016/j.bmc.2008.08.009
Activity of novel Cdc25 inhibitors and preliminary evaluation of their potentiation of chemotherapeutic drugs in human breast cancer cells, Life Sciences, vol.82, issue.5-6, pp.315-323, 2008. ,
DOI : 10.1016/j.lfs.2007.12.001
Synthesis and biological evaluation of dialkylsubstituted maleic anhydrides as novel inhibitors of CDC25 dual specificity phosphatases, Eur. J. Med. Chem, pp.42-243, 2007. ,
A Novel Synthetic Inhibitor of CDC25 Phosphatases, Cancer Research, vol.64, issue.9, pp.3320-3325, 2004. ,
DOI : 10.1158/0008-5472.CAN-03-3984
URL : https://hal.archives-ouvertes.fr/hal-00317444
Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases, Molecular Cancer Therapeutics, vol.4, issue.9, pp.1378-1387, 2005. ,
DOI : 10.1158/1535-7163.MCT-05-0168
URL : https://hal.archives-ouvertes.fr/hal-00317405
CDC25 Inhibitors as Anticancer Agents Are Moving Forward, Prévost G. P. CDC25 Inhibitors as Anticancer Agents Are Moving Forward, pp.857-862, 2008. ,
DOI : 10.2174/187152008786847701
IRC-083864, a novel bis quinone inhibitor of CDC25 phosphatases active against human cancer cells, International Journal of Cancer, vol.29, issue.6, pp.1449-1456, 2009. ,
DOI : 10.4161/cc.7.2.5306
Independent Mechanistic Inhibition of Cdc25 Phosphatases by a Natural Product Caulibugulone, Molecular Pharmacology, vol.71, issue.1, pp.71-185, 2007. ,
DOI : 10.1124/mol.106.028589
Discovery and Characterization of Novel Small Molecule Inhibitors of Human Cdc25B Dual Specificity Phosphatase, Molecular Pharmacology, vol.66, issue.4, pp.66-824, 2004. ,
DOI : 10.1124/mol.104.001784
Design, synthesis, and biological evaluation of novel naphthoquinone derivatives with CDC25 phosphatase inhibitory activity, Bioorganic & Medicinal Chemistry, vol.13, issue.16, pp.13-4871, 2005. ,
DOI : 10.1016/j.bmc.2005.05.005
URL : https://hal.archives-ouvertes.fr/hal-00317419
Unscheduled expression of CDC25B in S-phase leads to replicative stress and DNA damage, Molecular Cancer, vol.9, issue.1, pp.29-31, 2010. ,
DOI : 10.1186/1476-4598-9-29
Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase, Nature, vol.411, pp.102-107, 2001. ,
Dual phosphorylation controls Cdc25 phosphatases and mitotic entry, Nature Cell Biology, vol.36, issue.6, pp.545-551, 2003. ,
DOI : 10.1016/S0091-679X(08)60298-8
The G2/M checkpoint phosphatase cdc25C is located within centrosomes, The International Journal of Biochemistry & Cell Biology, vol.39, issue.9, pp.1707-1713, 2007. ,
DOI : 10.1016/j.biocel.2007.04.022
Diallylpolysulfides induce growth arrest and apoptosis, Int. J. Oncol, pp.36-743, 2010. ,
Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis, Oncogene, vol.23, issue.11, pp.2050-2056, 2004. ,
DOI : 10.1126/science.280.5363.593
URL : http://www.nature.com/onc/journal/v23/n11/pdf/1207394a.pdf
Role of the Cdc25A phosphatase in human breast cancer, Journal of Clinical Investigation, vol.106, issue.6, pp.763-761, 2000. ,
DOI : 10.1172/JCI9174
Halenaquinone and xestoquinone derivatives, inhibitors of CDC25B phosphatase from a Xestospongia sp, Bioorg. Med. Chem, pp.13-999, 2005. ,
Bioactivities of simplified adociaquinone B and naphthoquinone derivatives against Cdc25B, MKP-1, and MKP-3 phosphatases, Bioorganic & Medicinal Chemistry, vol.17, issue.6, pp.17-2276, 2009. ,
DOI : 10.1016/j.bmc.2008.10.090
Trans-3,4',5-trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells, Clin. Cancer Res, pp.10-5253, 2004. ,
Pharmacologic inhibition of CDC25 phosphatases impairs interphase microtubule dynamics and mitotic spindle assembly, Molecular Cancer Therapeutics, vol.6, issue.1, pp.318-325, 2007. ,
DOI : 10.1158/1535-7163.MCT-06-0299
URL : https://hal.archives-ouvertes.fr/hal-00317361
Synthesis and phosphatase inhibitory activity of analogs of sulfircin, Bioorganic & Medicinal Chemistry Letters, vol.7, issue.15, pp.2015-2020, 1997. ,
DOI : 10.1016/S0960-894X(97)00357-0
Cell cycle arrest in early mitosis and induction of caspase-dependent apoptosis in U937 cells by diallyltetrasulfide (Al2S4), Apoptosis, vol.16, issue.Suppl 9B, pp.641-654, 2009. ,
DOI : 10.4161/cc.1.3.126
Chk1 Kinase Negatively Regulates Mitotic Function of Cdc25A Phosphatase through 14-3-3 Binding, Molecular and Cellular Biology, vol.23, issue.21, pp.7488-7497, 2003. ,
DOI : 10.1128/MCB.23.21.7488-7497.2003
Discovery of a novel protein tyrosine phosphatase-1B inhibitor, KR61639: potential development as an antihyperglycemic agent, European Journal of Pharmacology, vol.485, issue.1-3, pp.485-333, 2004. ,
DOI : 10.1016/j.ejphar.2003.11.070
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Analytical Biochemistry, vol.162, issue.1, pp.156-159, 1987. ,
DOI : 10.1016/0003-2697(87)90021-2
Pro-apoptotic Role of Cdc25A, Journal of Biological Chemistry, vol.55, issue.23, pp.17833-17845, 2010. ,
DOI : 10.1002/cyto.a.10072
14-3-3 proteins associate with cdc25 phosphatases., Proceedings of the National Academy of Sciences, vol.92, issue.17, pp.7892-7896, 1995. ,
DOI : 10.1073/pnas.92.17.7892
What's new on CDC25 phosphatase inhibitors, Pharmacology & Therapeutics, vol.115, issue.1, pp.1-12, 2007. ,
DOI : 10.1016/j.pharmthera.2007.03.009
Human pEg3 kinase associates with and phosphorylates CDC25B phosphatase: a potential role for pEg3 in cell cycle regulation, Oncogene, vol.21, issue.50, pp.7630-7641, 2002. ,
DOI : 10.1093/emboj/18.8.2174
New combination therapies with cell cycle agents, Curr. Opin. Investig. Drugs, vol.9, pp.591-604, 2008. ,
Dual Regulation of Cdc25A by Chk1 and p53-ATF3 in DNA Replication Checkpoint Control, Journal of Biological Chemistry, vol.269, issue.7, pp.284-4132, 2009. ,
DOI : 10.1073/pnas.0505585102
A simple method to prepare unsymmetrical di- tri- and tetrasulfides, Tetrahedron Letters, vol.35, issue.30 ,
DOI : 10.1016/S0040-4039(00)73505-2
Synthesis of a novel class of cdc25A inhibitors from vitamin D 3, Bioorganic & Medicinal Chemistry Letters, vol.10, issue.7, pp.615-617, 2000. ,
DOI : 10.1016/S0960-894X(00)00065-2
Dual mode of degradation of Cdc25 A phosphatase, The EMBO Journal, vol.21, issue.18, pp.4875-4884, 2002. ,
DOI : 10.1093/emboj/cdf491
Diallyl disulfide (DADS) increases histone acetylation and p21waf1/cip1 expression in human colon tumor cell lines, Carcinogenesis, vol.25, issue.7, pp.1227-1236, 2004. ,
DOI : 10.1093/carcin/bgh123
Regulation of Cdc25A Half-life in Interphase by Cyclin-dependent Kinase 2 Activity, Journal of Biological Chemistry, vol.9, issue.34, pp.31838-31842, 2003. ,
DOI : 10.1073/pnas.95.19.11324
Phosphorylation of CDC25B by Aurora-A at the centrosome contributes to the G2-M transition, Journal of Cell Science, vol.117, issue.12, pp.2523-2531, 2004. ,
DOI : 10.1242/jcs.01108
URL : https://hal.archives-ouvertes.fr/hal-00317440
Polyprenyl-hydroquinones and -furans from three marine sponges inhibit the cell cycle regulating phosphatase CDC25A, Natural Product Research, vol.22, issue.1, 2004. ,
DOI : 10.1007/BF01957811
URL : https://hal.archives-ouvertes.fr/hal-00020132
Epistatic gene interactions in the control of division in fission yeast, Nature, vol.115, issue.5712, pp.428-430, 1979. ,
DOI : 10.1042/bst0051191
Crystal Structure of the Catalytic Domain of the Human Cell Cycle Control Phosphatase, Cdc25A, Crystal structure of the catalytic domain of the human cell cycle control phosphatase, pp.617-625, 1998. ,
DOI : 10.1016/S0092-8674(00)81190-3
Discovery and characterization of a novel inhibitor of CDC25B, LGH00045, Acta Pharmacol. Sin, vol.10, pp.1268-1274, 2008. ,
Piwnica-Worms H. Normal Cell cycle and checkpoint responses in mice and cells lacking CDC25B and CDC25C protein phosphatases, Mol. Cell. Biol, pp.25-2853, 2005. ,
Estimates of cancer incidence and mortality in Europe, 2008. ,
Cytoplasmic accumulation of CDC25B phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells, J. Cell Sci, vol.109, pp.1081-1093, 1996. ,
Hyperphosphorylation of the N-terminal Domain of Cdc25 Regulates Activity toward Cyclin B1/Cdc2 But Not Cyclin A/Cdk2, Journal of Biological Chemistry, vol.101, issue.45, pp.272-28607, 1997. ,
DOI : 10.1038/sj.onc.1201254
CDC25 phosphatases as potential human oncogenes, CDC25 phosphatases as potential human oncogenes, pp.1575-1577, 1995. ,
DOI : 10.1126/science.7667636
Cdc25 cell-cycle phosphatase as a target of c-myc, Nature, vol.382, issue.6591, pp.511-517, 1996. ,
DOI : 10.1038/382511a0
Antisense phosphorothioate oligonucleotides specifically down-regulate cdc25B causing S-phase delay and persistent antiproliferative effects, International Journal of Cancer, vol.271, issue.5, pp.720-728, 1998. ,
DOI : 10.1074/jbc.271.9.5118
URL : http://onlinelibrary.wiley.com/doi/10.1002/(SICI)1097-0215(19980529)76:5<720::AID-IJC18>3.0.CO;2-7/pdf
de Laubenfels, Journal of the American Chemical Society, vol.118, issue.36, pp.8759-8760, 1996. ,
DOI : 10.1021/ja961961+
Expression and functional significance of CDC25B in human pancreatic ductal adenocarcinoma, Oncogene, vol.23, issue.1, pp.71-81, 2004. ,
DOI : 10.1006/dbio.1995.1207
Pharmacology and antitumor activity of a quinolinedione CDC25 phosphatase inhibitor DA3003-1 (NSC 663284), Anticancer Res, vol.27, pp.3067-3074, 2007. ,
Studies on Menadione as an Inhibitor of the cdc25 Phosphatase, Bioorganic Chemistry, vol.25, issue.1 ,
DOI : 10.1006/bioo.1996.1052
Checkpoint Kinase 1 Regulates Diallyl Trisulfide-induced Mitotic Arrest in Human Prostate Cancer Cells, Journal of Biological Chemistry, vol.1602, issue.31, pp.28519-28528, 2005. ,
DOI : 10.1054/drup.2001.0213
Molecular targets of cancer chemoprevention by garlic-derived organosulfides, Acta Pharmacologica Sinica, vol.117, issue.9, pp.1355-1364, 2007. ,
DOI : 10.2174/1566524033479465
Cyclin-dependent kinases and cell-cycle transitions: does one fit all?, Nature Reviews Molecular Cell Biology, vol.10, issue.11 ,
DOI : 10.1128/MCB.19.10.7011
Phosphorylation and activation of human CDC25-C by cdc2 -cyclin B and its involvement in the self-amplification of MPF at mitosis, EMBO J, vol.12, pp.53-63, 1993. ,
Activation of the phosphatase activity of human CDC25A by a cdk2- cyclin E dependent phosphorylation at the G1/S transition, EMBO J, vol.13, pp.4302-4310, 1994. ,
Casein kinase 1 functions as both penultimate and ultimate kinase in regulating Cdc25A destruction, Oncogene, vol.6, issue.23, pp.3324-3334, 2010. ,
DOI : 10.1128/MCB.19.9.6379
Dnacin A1 and dnacin B1 are antitumor antibiotics that inhibit cdc25B phosphatase activity, Biochemical Pharmacology, vol.48, issue.11, pp.48-2139, 1994. ,
DOI : 10.1016/0006-2952(94)90516-9
Diallyl trisulfide suppresses the proliferation and induces apoptosis of human colon cancer cells through oxidative modification of betatubulin, J. Biol. Chem, pp.280-41487, 2005. ,
Garlic-derived Sallylmercaptocysteine is a novel in vivo antimetastatic agent for androgen-independent prostate cancer ,
Allium vegetables and risk of prostate cancer:a population-based study, J. Natl. Cancer Inst, pp.94-1648, 2002. ,
Synthesis and biological evaluation of (??)-cryptotanshinone and its simplified analogues as potent CDC25 inhibitors, Tetrahedron, vol.61, issue.7, pp.1863-1870, 2005. ,
DOI : 10.1016/j.tet.2004.12.033
Synthesis of tanshinone IIA analogues and their inhibitory activities against Cdc25 phosphatases, Chinese Chemical Letters, vol.20, issue.12, pp.1461-1464, 2009. ,
DOI : 10.1016/j.cclet.2009.07.008
Biological properties of garlic and garlic-derived organosulfur compounds, Environmental and Molecular Mutagenesis, vol.10, issue.3, pp.247-265, 2009. ,
DOI : 10.3748/wjg.v10.i18.2731
Perspective on Recent Developments on Sulfur-Containing Agents and Hydrogen Sulfide Signaling, Planta Medica, vol.74, issue.13, pp.1580-1592, 2008. ,
DOI : 10.1055/s-0028-1088299
Sulfides in Allium Vegetables In: Chemoprevention of cancer and DNA damage by dietary factors, pp.663-684, 2009. ,
Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes, Science, vol.275, issue.5297, pp.218-220, 1997. ,
DOI : 10.1126/science.275.5297.218
CDC25A is a novel phosphatase functioning early in the cell cycle, EMBO J, vol.13, pp.1549-1556, 1994. ,
Cdc25B Dual-Specificity Phosphatase Inhibitors Identified in a High-Throughput Screen of the NIH Compound Library, Lazo J. S. CDC25B Dual-Specificity Phosphatase Inhibitors Identified in a High-Throughput Screen of the NIH Compound Library, pp.250-265, 2009. ,
DOI : 10.1089/adt.2008.186
Inhibition of carcinogenesis by tea constituents, Seminars in Cancer Biology, vol.17, issue.5, pp.395-402, 2007. ,
DOI : 10.1016/j.semcancer.2007.06.013
Vitamin K3 inhibits growth of human hepatoma HepG2 cells by decreasing activities of both p34 cdc2 kinase and phosphatase, Biochem. Biophys. Res. Commun, pp.190-907, 1993. ,
Cdc25A localisation and shuttling: characterisation of sequences mediating nuclear export and import, Experimental Cell Research, vol.303, issue.1, pp.89-100, 2005. ,
DOI : 10.1016/j.yexcr.2004.09.012
??-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases, Proceedings of the National Academy of Sciences, vol.101, issue.13, pp.6279-6284, 2005. ,
DOI : 10.1073/pnas.0307700101
Antitumor and anticarcinogenic actions of Cpd 5: a new class of protein phosphatase inhibitor, Carcinogenesis, vol.24, issue.3, pp.411-416, 2003. ,
DOI : 10.1093/carcin/24.3.411
H32, a non-quinone sulfone analog of vitamin K3, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating ERK, Cancer Biology & Therapy, vol.5, issue.10, pp.1340-1347, 2006. ,
DOI : 10.4161/cbt.5.10.3223
PM-20, a novel inhibitor of Cdc25A, induces extracellular signal-regulated kinase 1/2 phosphorylation and inhibits hepatocellular carcinoma growth in vitro and in vivo, Molecular Cancer Therapeutics, vol.5, issue.6, pp.1511-1519, 2006. ,
DOI : 10.1158/1535-7163.MCT-05-0485
Fluorinated Cpd 5, a pure arylating K-vitamin derivative, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating MAPK, Biochemical Pharmacology, vol.72, issue.10, pp.72-1217, 2006. ,
DOI : 10.1016/j.bcp.2006.07.024
2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis, Cancer Chemotherapy and Pharmacology, vol.24, issue.2080, pp.62-831, 2007. ,
DOI : 10.4161/cbt.5.10.3223
Targeting Multiple Signaling Pathways by Green Tea Polyphenol (???)-Epigallocatechin-3-Gallate: Figure 1., Cancer Research, vol.66, issue.5, pp.2500-2505, 2006. ,
DOI : 10.1158/0008-5472.CAN-05-3636
Anticarcinogenic Properties of Garlic: A Review, Critical Reviews in Food Science and Nutrition, vol.58, issue.6 ,
DOI : 10.1021/jf00015a002
Differential mitotic degradation of the CDC25B phosphatase variants, Oncogene, vol.14, issue.57, pp.7847-7858, 2007. ,
DOI : 10.1038/sj.onc.1208617
URL : https://hal.archives-ouvertes.fr/hal-00317345
Inhibition of overexpressed CDC-25.1 phosphatase activity by flavone in Caenorhabditis elegans, Molecules and Cells, vol.46, issue.3, pp.345-350, 2009. ,
DOI : 10.1007/s10059-009-0044-9
Resveratrol inhibits cell proliferation and induces apoptosis of human breast carcinoma MCF-7 cells, Oncology Reports, pp.11-441, 2004. ,
DOI : 10.3892/or.11.2.441
Development of Novel Thiazolopyrimidines as CDC25B Phosphatase Inhibitors, ChemMedChem, vol.49, issue.4, pp.633-648, 2009. ,
DOI : 10.4161/cc.7.2.5306
Cdc25 Phosphatases and Cancer, Chemistry & Biology, vol.11, issue.8, pp.1043-1051, 2004. ,
DOI : 10.1016/j.chembiol.2004.07.007
Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives, Cancer Letters, vol.269, issue.2, pp.243-261, 2008. ,
DOI : 10.1016/j.canlet.2008.03.057
The CDC25B phosphatase is essential for the G2/M phase transition in human cells, J. Cell Sci, vol.111, pp.2445-2453, 1998. ,
Cdc25B Phosphatase Inhibitors in Cancer Therapy: Latest Developments, Trends and Medicinal Chemistry Perspective, Anti-Cancer Agents in Medicinal Chemistry, vol.8, issue.8, pp.843-856, 2008. ,
DOI : 10.2174/187152008786847783
CDC25A and B Dual-Specificity Phosphatase Inhibitors: Potential Agents for Cancer Therapy, Current Medicinal Chemistry, vol.16, issue.15, pp.1831-1849, 2009. ,
DOI : 10.2174/092986709788186084
Inhibitors of Cdc25 phosphatases as anticancer agents: a patent review, Expert Opinion on Therapeutic Patents, vol.303, issue.3, pp.405-425, 2010. ,
DOI : 10.1126/science.1092472
Discovery and Biological Evaluation of a New Family of Potent Inhibitors of the Dual Specificity Protein Phosphatase Cdc25, Journal of Medicinal Chemistry, vol.44, issue.24, pp.44-4042, 2001. ,
DOI : 10.1021/jm0102046
Identification of a Potent and Selective Pharmacophore for Cdc25 Dual Specificity Phosphatase Inhibitors., Molecular Pharmacology, vol.61, issue.4, pp.61-720, 2002. ,
DOI : 10.1124/mol.61.4.720
Is Cdc25 a Druggable Target?, Anti-Cancer Agents in Medicinal Chemistry, vol.8, issue.8, pp.837-842, 2008. ,
DOI : 10.2174/187152008786847738
CDC25B Phosphorylation by p38 and MK-2, Cell Cycle, vol.5, issue.15, pp.1649-1653, 2006. ,
DOI : 10.4161/cc.5.15.3006
URL : https://hal.archives-ouvertes.fr/hal-00317373
UV-induced downregulation of the CDC25B protein in human cells, FEBS Letters, vol.8, issue.6, pp.1199-1204, 2010. ,
DOI : 10.4161/cc.8.2.7595
Cdc25B cooperates with Cdc25A to induce mitosis but has a unique role in activating cyclin B1???Cdk1 at the centrosome, The Journal of Cell Biology, vol.269, issue.1, pp.171-206, 2005. ,
DOI : 10.1074/jbc.M305178200
Design, Synthesis, and Evaluation of Novel Thienopyrrolizinones as Antitubulin Agents, Journal of Medicinal Chemistry, vol.47, issue.6 ,
DOI : 10.1021/jm030961z
Distinct modes of deregulation of the proto-oncogenic Cdc25A phosphatase in human breast cancer cell lines, Oncogene, vol.22, issue.50, pp.8063-8071, 2003. ,
DOI : 10.1038/35044005
A key kinase in cell cycle control and a target for drugs ?, Cell cycle, vol.4, pp.572-577, 2005. ,
Coscinosulfate, a CDC25 phosphatase inhibitor from the sponge Coscinoderma mathewsi, Bioorganic & Medicinal Chemistry, vol.9, issue.11, pp.3049-3054, 2001. ,
DOI : 10.1016/S0968-0896(01)00208-5
URL : https://hal.archives-ouvertes.fr/hal-00086659
Induction of mammary gland hyperplasia in transgenic mice over-expressing human Cdc25B, Oncogene, vol.18, issue.32, pp.4564-4576, 1999. ,
DOI : 10.1038/351194b0
Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance, Nature Cell Biology, vol.7, issue.6, pp.591-600, 2005. ,
DOI : 10.1016/j.ccr.2005.01.010
Regulation of G2/M events by Cdc25A through phosphorylation-dependent modulation of its stability, The EMBO Journal, vol.21, issue.21, pp.5911-5920, 2002. ,
DOI : 10.1093/emboj/cdf567
MAPKAP Kinase-2 Is a Cell Cycle Checkpoint Kinase that Regulates the G2/M Transition and S Phase Progression in Response to UV Irradiation, Molecular Cell, vol.17, issue.1, pp.17-37, 2005. ,
DOI : 10.1016/j.molcel.2004.11.021
Linkage of ATM to Cell Cycle Regulation by the Chk2 Protein Kinase, Science, vol.282, issue.5395, pp.1893-1897, 1998. ,
DOI : 10.1126/science.282.5395.1893
Application of generalized linear models to the analysis of toxicity tests data, Environ. Monit. Assess, vol.23, pp.153-163, 1992. ,
Prognostic implication of CDC25A and cyclin E expression on primary breast cancer patients, Cell Biology International, vol.33, issue.10, pp.33-1050, 2009. ,
DOI : 10.1016/j.cellbi.2009.06.016
Le cycle de division cellulaire et sa régulation, pp.311-326, 2003. ,
NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint, NEK11 regulates CDC25A degradation and the IRinduced G2/M checkpoint, pp.1247-1253, 2009. ,
DOI : 10.1128/MCB.21.10.3445-3450.2001
New syntheses of trisulphides, J. Chem. Soc, pp.4850-4853, 1961. ,
(-)-Epigallocatechin gallate can prevent cisplatin-induced lung tumorigenesis in A/J mice, Carcinogenesis, vol.21, issue.5, pp.915-919, 2000. ,
DOI : 10.1093/carcin/21.5.915
CDC25B Phosphorylated by pEg3 Localizes to the Centrosome and the Spindle Poles at Mitosis, Cell Cycle, vol.4, issue.6, pp.806-811, 2005. ,
DOI : 10.4161/cc.4.6.1716
URL : https://hal.archives-ouvertes.fr/hal-00317422
Receptor-Based Virtual Ligand Screening for the Identification of Novel CDC25 Phosphatase Inhibitors, Journal of Chemical Information and Modeling, vol.48, issue.1, pp.48-157, 2008. ,
DOI : 10.1021/ci700313e
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, Journal of Immunological Methods, vol.65, issue.1-2, pp.55-63, 1983. ,
DOI : 10.1016/0022-1759(83)90303-4
Polysulfides as Biologically Active Ingredients of Garlic, ChemInform, vol.5, issue.35 ,
DOI : 10.1002/chin.200735239
Cell cycle regulation by the Cdc25 phosphatase family, Prog. Cell Cycle Res, vol.4, pp.107-114, 2000. ,
DOI : 10.1007/978-1-4615-4253-7_10
Fluorinated NSC as a Cdc25 inhibitor, Bioorganic & Medicinal Chemistry Letters, vol.17, issue.8, pp.2351-2354, 2007. ,
DOI : 10.1016/j.bmcl.2006.12.046
Discovery of Novel Cdc25 Phosphatase Inhibitors with Micromolar Activity Based on the Structure-Based Virtual Screening, Journal of Medicinal Chemistry, vol.51, issue.18, pp.51-5533, 2008. ,
DOI : 10.1021/jm701157g
Structure-based de novo design and biochemical evaluation of novel Cdc25 phosphatase inhibitors, Bioorganic & Medicinal Chemistry Letters, vol.19, issue.15, pp.4330-4334, 2009. ,
DOI : 10.1016/j.bmcl.2009.05.084
Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors, Bioorganic & Medicinal Chemistry Letters, vol.19, issue.15, pp.4372-4375, 2009. ,
DOI : 10.1016/j.bmcl.2009.05.078
-Nitrophenyl Phosphate from QM/MM-MFEP Calculations, The Journal of Physical Chemistry B, vol.113, issue.15, pp.5217-5224, 2009. ,
DOI : 10.1021/jp805137x
URL : http://europepmc.org/articles/pmc2712249?pdf=render
Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A, Nature Cell Biology, vol.7, issue.4, pp.12-400, 2010. ,
DOI : 10.1038/ncb2041
Novel hydroxyl naphthoquinones with potent Cdc25 antagonizing and growth inhibitory properties, Molecular Cancer Therapeutics, vol.4, issue.4, pp.595-602, 2005. ,
DOI : 10.1158/1535-7163.MCT-04-0274
Dual G1 and G2 phase inhibition by a novel, selective CDC25 inhibitor 7-Chloro-6-(2-morpholin-4-ylethylamino)-quinoline-5,8-dione, J. Biol. Chem, pp.277-46877, 2002. ,
Hemizygous Disruption of Cdc25A Inhibits Cellular Transformation and Mammary Tumorigenesis in Mice, Cancer Research, vol.67, issue.14, pp.6605-6611, 2007. ,
DOI : 10.1158/0008-5472.CAN-06-4815
Crystal structure of the catalytic subunit of CDC25B required for G2/M phase transition of the cell cycle, J. Mol ,
Redox Regulation of the Cdc25 Phosphatases, Antioxidants & Redox Signaling, vol.7, issue.5-6, pp.761-767, 2005. ,
DOI : 10.1089/ars.2005.7.761
Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2., Proceedings of the National Academy of Sciences, vol.87, issue.13, pp.5139-5143, 1990. ,
DOI : 10.1073/pnas.87.13.5139
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints, Annual Review of Biochemistry, vol.73, issue.1, pp.73-112, 2004. ,
DOI : 10.1146/annurev.biochem.73.011303.073723
Redox Regulation of Cdc25C, Journal of Biological Chemistry, vol.1176, issue.23, pp.20535-20540, 2002. ,
DOI : 10.1002/(SICI)1097-4652(199810)177:1<148::AID-JCP16>3.0.CO;2-9
Garlic and associated allyl sulfur components inhibit N-methyl-N-nitrosourea induced rat mammary carcinogenesis, Cancer Letters, vol.102, issue.1-2, pp.199-204, 1996. ,
DOI : 10.1016/0304-3835(96)04160-2
Potential role of organic sulfur compounds from Allium species in cancer prevention and therapy, Phytochemistry Reviews, vol.46, issue.2, pp.349-368, 2009. ,
DOI : 10.1016/B978-0-12-642760-8.50005-3
Targeting the Cell Cycle: A New Approach to Cancer Therapy, Journal of Clinical Oncology, vol.23, issue.36, pp.9408-9421, 2005. ,
DOI : 10.1200/JCO.2005.01.5594
Design and synthesis of dysidiolide analogs from vitamin D3: novel class of Cdc25A inhibitors, Bioorganic & Medicinal Chemistry Letters, vol.14, issue.12, pp.3291-3294, 2004. ,
DOI : 10.1016/j.bmcl.2004.03.100
Design and synthesis of novel Cdc25A-inhibitors having phosphate group as a hydrophilic residue, Bioorganic & Medicinal Chemistry Letters, vol.14, issue.16, pp.4339-4342, 2004. ,
DOI : 10.1016/j.bmcl.2004.05.083
Design and synthesis of N-alkyl oxindolylidene acetic acids as a new class of potent Cdc25A inhibitors, Bioorganic & Medicinal Chemistry Letters, vol.18, issue.11, pp.3350-3353, 2008. ,
DOI : 10.1016/j.bmcl.2008.04.027
Cdc25A Serine 123 Phosphorylation Couples Centrosome Duplication with DNA Replication and Regulates Tumorigenesis, Molecular and Cellular Biology, vol.28, issue.24, pp.7442-7450, 2008. ,
DOI : 10.1128/MCB.00138-08
Remote hot spots mediate protein substrate recognition for the Cdc25 phosphatase, Proceedings of the National Academy of Sciences, vol.14, issue.1, pp.16437-16441, 2004. ,
DOI : 10.1016/0263-7855(96)00018-5
S-phase induction by adenovirus E1A requires activation of CDC25A tyrosine phosphatase, Oncogene, vol.12, pp.2549-2554, 1996. ,
Bioactive food components and cancer risk reduction, Journal of Cellular Biochemistry, vol.2, issue.1, pp.339-356, 2008. ,
DOI : 10.1111/j.1349-7006.1997.tb00440.x
Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer, Life Sciences, vol.79, issue.25, pp.2329-2336, 2006. ,
DOI : 10.1016/j.lfs.2006.07.036
Cancer chemoprevention with dietary phytochemicals, Nature Reviews Cancer, vol.3, issue.10, pp.768-780, 2003. ,
DOI : 10.1038/nrc1189
Synthesis of the novel analogues of dysidiolide and their structure???activity relationship, Bioorganic & Medicinal Chemistry Letters, vol.10, issue.22, pp.2571-2574, 2000. ,
DOI : 10.1016/S0960-894X(00)00527-8
One-Pot Synthesis of 7-Hydroxythieno[3,2-b]pyridin-5(4H)-ones., ChemInform, vol.38, issue.48, pp.2153-2156, 2007. ,
DOI : 10.1002/chin.200748135
Human Cdc25A phosphatase has a non-redundant function in G2 phase by activating Cyclin A-dependent kinases, FEBS Letters, vol.5, issue.4, pp.841-847, 2009. ,
DOI : 10.1038/ncb918
/M Transition, Journal of Biological Chemistry, vol.19, issue.22, pp.16978-16990, 2010. ,
DOI : 10.1038/sj.emboj.7601136
Plk1 promotes nuclear translocation of human Cdc25C during prophase, EMBO Reports, vol.3, issue.4, pp.341-348, 2002. ,
DOI : 10.1093/embo-reports/kvf069
Functional cdc25C Dual-Specificity Phosphatase Is Required for S-Phase Entry in Human Cells, Molecular Biology of the Cell, vol.14, issue.7, pp.2984-2998, 2003. ,
DOI : 10.1091/mbc.E02-08-0515
Nuclear export signal in CDC25B, Biochemical and Biophysical Research Communications, vol.316, issue.1, pp.316-226, 2004. ,
DOI : 10.1016/j.bbrc.2004.02.039
Stressactivated mitogen-activated protein kinases c-Jun NH2-terminal kinase and p38 target CDC25B for degradation, Cancer Res, pp.69-6438, 2009. ,
Synthesis and biological evaluation of novel coumarin-based inhibitors of Cdc25 phosphatases, Bioorganic & Medicinal Chemistry Letters, vol.20, issue.19, pp.5827-5830, 2010. ,
DOI : 10.1016/j.bmcl.2010.07.130
Restarting the cell cycle when the checkpoint comes to a halt ,
The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer, Cell Proliferation, vol.59, issue.3, pp.131-149, 2003. ,
DOI : 10.1101/gad.827700
Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes, BMC Cancer, vol.5, issue.1, pp.233-244, 2010. ,
DOI : 10.1038/ncb994
Over-expression of P-glycoprotein and glutathione S-transferase PI in MCF-7 cells selected for vincristine resistancein vitro, International Journal of Cancer, vol.1, issue.2, pp.241-246, 1992. ,
DOI : 10.1128/MCB.5.8.2114
Synthesis and biological evaluation of caulibugulones A ,
Differential effects of allyl sulfides from garlic essential oil on cell cycle regulation in human liver tumor cells, Food and Chemical Toxicology, vol.42, issue.12, pp.42-1937, 2004. ,
DOI : 10.1016/j.fct.2004.07.008
Vitamin K3 induces cell cycle arrest and cell death by inhibiting Cdc25 phosphatase, European Journal of Cancer, vol.35, issue.9, pp.1388-1393, 1999. ,
DOI : 10.1016/S0959-8049(99)00156-2
Differential Effects of Garlic Oil and Its Three Major Organosulfur Components on the Hepatic Detoxification System in Rats, Journal of Agricultural and Food Chemistry, vol.50, issue.2, pp.378-383, 2002. ,
DOI : 10.1021/jf010937z
Induction of apoptosis in tumor cells by naturally occurring sulfur-containing compounds, Mutation Research/Reviews in Mutation Research, vol.589, issue.2, pp.81-102, 2005. ,
DOI : 10.1016/j.mrrev.2004.11.001
Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2, Oncogene, vol.23, issue.33, pp.5594-5606, 2004. ,
DOI : 10.1093/jnci/81.2.162
Diallyl trisulfide-induced G2???M???phase cell cycle arrest in human prostate cancer cells is caused by reactive oxygen species-dependent destruction and hyperphosphorylation of Cdc25C, Oncogene, vol.24, issue.41, pp.6256-6268, 2005. ,
DOI : 10.1093/jnci/81.2.162
Diallyl Trisulfide Suppresses Growth of PC-3 Human Prostate Cancer Xenograft In vivo in Association with Bax and Bak Induction, Clinical Cancer Research, vol.12, issue.22 ,
DOI : 10.1158/1078-0432.CCR-06-1273
Diallyl trisulfide-induced apoptosis in human cancer cells is linked to checkpoint kinase 1-mediated mitotic arrest, Molecular Carcinogenesis, vol.117, issue.11, pp.48-1018, 2009. ,
DOI : 10.1091/mbc.6.2.185
CDC25A mRNA levels significantly correlate with Ki-67 expression in human glioma samples, Journal of Neuro-Oncology, vol.59, issue.1, 2010. ,
DOI : 10.2174/187152008786847738
kinase, Journal of Zhejiang University SCIENCE, vol.6, issue.7, pp.6-656, 2005. ,
DOI : 10.1631/jzus.2005.B0656
URL : https://hal.archives-ouvertes.fr/hal-00700472
Diallyl disulfide-induced G2/M arrest of human gastric cancer MGC803 cells involves activation of p38 MAP kinase pathways, World Journal of Gastroenterology, vol.10, issue.18, pp.2731-2734, 2004. ,
DOI : 10.1128/jvi.76.19.9763-9772.2002
Cytotoxicity of new alkylamino- and phenylamino-containing polyfluorinated derivatives of 1,4-naphthoquinone, European Journal of Medicinal Chemistry, vol.45, issue.6, pp.45-2321, 2010. ,
DOI : 10.1016/j.ejmech.2010.02.009
Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1?? and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells, Molecular Cancer Therapeutics, vol.4, issue.10, pp.1465-1474, 2005. ,
DOI : 10.1158/1535-7163.MCT-05-0198
LGH00031, a novel ortho-quinonoid inhibitor of cell division cycle 25B, inhibits human cancer cells via ROS generation, Acta Pharmacologica Sinica, vol.68, issue.9, pp.30-1359, 2009. ,
DOI : 10.1074/jbc.M104889200